Bibliografías temáticas / Vascular endothelial growth factor / Artículos de revistas

Artículos de revistas sobre el tema "Vascular endothelial growth factor"

Siga este enlace para ver otros tipos de publicaciones sobre el tema: Vascular endothelial growth factor.
Autor: Grafiati
Publicado: 4 de junio de 2021
Última modificación: 20 de febrero de 2023

Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros

Elija tipo de fuente:

Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Vascular endothelial growth factor".

Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.

También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.

Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.

1

Ferrara, Napoleone. "Vascular Endothelial Growth Factor". Arteriosclerosis, Thrombosis, and Vascular Biology 29, n.º 6 (junio de 2009): 789–91. http://dx.doi.org/10.1161/atvbaha.108.179663.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
2

Wirostko, Barbara M. "Vascular Endothelial Growth Factor". Ophthalmology 114, n.º 10 (octubre de 2007): 1954–55. http://dx.doi.org/10.1016/j.ophtha.2007.05.018.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
3

Ferrara, N. "Vascular endothelial growth factor". European Journal of Cancer 32, n.º 14 (diciembre de 1996): 2413–22. http://dx.doi.org/10.1016/s0959-8049(96)00387-5.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
4

Zachary, Ian. "Vascular endothelial growth factor". International Journal of Biochemistry & Cell Biology 30, n.º 11 (noviembre de 1998): 1169–74. http://dx.doi.org/10.1016/s1357-2725(98)00082-x.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
5

Clauss, Matthias y Wolfgang Schaper. "Vascular Endothelial Growth Factor". Circulation Research 86, n.º 3 (18 de febrero de 2000): 251–52. http://dx.doi.org/10.1161/01.res.86.3.251.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
6

Ferrara, Napoleone. "Vascular endothelial growth factor". Trends in Cardiovascular Medicine 3, n.º 6 (noviembre de 1993): 244–50. http://dx.doi.org/10.1016/1050-1738(93)90046-9.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
7

Yip-Schneider, Michele y C. Max Schmidt. "Vascular Endothelial Growth Factor". Journal of the American College of Surgeons 219, n.º 3 (septiembre de 2014): 591–92. http://dx.doi.org/10.1016/j.jamcollsurg.2014.06.009.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
8

Aziz, Reem A. Abdel. "Serum Vascular Endothelial Growth Factor in Children with Beta Thalassemia Major". Journal of Medical Science And clinical Research 04, n.º 12 (28 de diciembre de 2016): 14955–63. http://dx.doi.org/10.18535/jmscr/v4i12.107.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
9

Rama, K. y D. Kanmani. "Implication of VEGF (Vascular Endothelial Growth Factor) in Epithelial Ovarian Neoplasms". Indian Journal of Pathology: Research and Practice 5, n.º 3 (2016): 283–90. http://dx.doi.org/10.21088/ijprp.2278.148x.5316.8.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
10

Arkonac, Burak M., Lauren C. Foster, Nicholas E. S. Sibinga, Cam Patterson, Kaihua Lai, Jer-Chia Tsai, Mu-En Lee, Mark A. Perrella y Edgar Haber. "Vascular endothelial growth factor induces heparin-binding epidermal growth factor-like growth factor in vascular endothelial cells." Journal of Biological Chemistry 273, n.º 15 (abril de 1998): 9352. http://dx.doi.org/10.1016/s0021-9258(18)49640-8.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
11

Arkonac, Burak M., Lauren C. Foster, Nicholas E. S. Sibinga, Cam Patterson, Kaihua Lai, Jer-Chia Tsai, Mu-En Lee, Mark A. Perrella y Edgar Haber. "Vascular Endothelial Growth Factor Induces Heparin-binding Epidermal Growth Factor-like Growth Factor in Vascular Endothelial Cells". Journal of Biological Chemistry 273, n.º 8 (20 de febrero de 1998): 4400–4405. http://dx.doi.org/10.1074/jbc.273.8.4400.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
12

Barus, Jimmy, Ismail Setyopranoto, Ahmad Sadewa y Samekto Wibowo. "The Role of Vascular Endothelial Growth Factor in Diabetic Polyneuropathy". International Journal of Medical Reviews and Case Reports 2, Reports in Surgery and Dermatolo (2019): 1. http://dx.doi.org/10.5455/ijmrcr.vascular-endothelial-growth-factor-diabetic-polyneuropathy.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
13

Waisbourd, Michael, Anat Loewenstein, Michaella Goldstein y Igal Leibovitch. "Targeting Vascular Endothelial Growth Factor". Drugs & Aging 24, n.º 8 (2007): 643–62. http://dx.doi.org/10.2165/00002512-200724080-00003.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
14

Maitland, Michael L., Xing Jian Lou, Jacqueline Ramirez, Apurva A. Desai, Dorit S. Berlin, Howard L. McLeod, Ralph R. Weichselbaum, Mark J. Ratain, Russ B. Altman y Teri E. Klein. "Vascular endothelial growth factor pathway". Pharmacogenetics and Genomics 20, n.º 5 (mayo de 2010): 346–49. http://dx.doi.org/10.1097/fpc.0b013e3283364ed7.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
15

Krupitskaya, Yelena y Heather Wakelee. "Vascular Endothelial Growth Factor Pathway". Journal of Thoracic Oncology 4, n.º 11 (noviembre de 2009): S1071—S1073. http://dx.doi.org/10.1097/01.jto.0000361755.32660.a1.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
16

Bertelmann, Thomas, Stephan Schulze, Reka Bölöni, Walter Sekundo, Sebastian Irle, Thomas Stief y Stefan Mennel. "Intravitreal vascular endothelial growth factor". Graefe's Archive for Clinical and Experimental Ophthalmology 252, n.º 4 (4 de febrero de 2014): 583–88. http://dx.doi.org/10.1007/s00417-014-2577-7.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
17

Cai, Weibo. "Multimodality imaging of vascular endothelial growth factor and vascular endothelial growth factor receptor expression". Frontiers in Bioscience 12, n.º 8-12 (2007): 4267. http://dx.doi.org/10.2741/2386.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
18

Lazarus, A. y E. Keshet. "Vascular Endothelial Growth Factor and Vascular Homeostasis". Proceedings of the American Thoracic Society 8, n.º 6 (1 de noviembre de 2011): 508–11. http://dx.doi.org/10.1513/pats.201102-021mw.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
19

Hagberg, Carolina, Annika Mehlem, Annelie Falkevall, Lars Muhl y Ulf Eriksson. "Endothelial Fatty Acid Transport: Role of Vascular Endothelial Growth Factor B". Physiology 28, n.º 2 (marzo de 2013): 125–34. http://dx.doi.org/10.1152/physiol.00042.2012.

Texto completo
Resumen
Dietary lipids present in the circulation have to be transported through the vascular endothelium to be utilized by tissue cells, a vital mechanism that is still poorly understood. Vascular endothelial growth factor B (VEGF-B) regulates this process by controlling the expression of endothelial fatty acid transporter proteins (FATPs). Here, we summarize research on the role of the vascular endothelium in nutrient transport, with emphasis on VEGF-B signaling.
Los estilos APA, Harvard, Vancouver, ISO, etc.
20

Zhao, B., G. Smith, J. Cai, A. Ma y M. Boulton. "Vascular endothelial growth factor C promotes survival of retinal vascular endothelial cells via vascular endothelial growth factor receptor-2". British Journal of Ophthalmology 91, n.º 4 (30 de agosto de 2006): 538–45. http://dx.doi.org/10.1136/bjo.2006.101543.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
21

A S, Dr Divya. "Plasma Vascular Endothelial Growth Factor (VEGF) In Ischemic Stroke – A Comparative Study". Journal of Medical Science And clinical Research 05, n.º 03 (23 de mayo de 2017): 19274–81. http://dx.doi.org/10.18535/jmscr/v5i3.152.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
22

Arisakti, Miatina Artisnita y Muhtarum Yusuf. "Correlation between vascular endothelial growth factor expression and cervical lymph node carcinoma". International Journal of Psychosocial Rehabilitation 24, n.º 02 (13 de febrero de 2020): 4072–80. http://dx.doi.org/10.37200/ijpr/v24i2/pr200728.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
23

Matsuura, Akira, Seinosuke Kawashima, Wataru Yamochi, Ken-ichi Hirata, Tsutomu Yamaguchi, Noriaki Emoto y Mitsuhiro Yokoyama. "Vascular Endothelial Growth Factor Increases Endothelin-Converting Enzyme Expression in Vascular Endothelial Cells". Biochemical and Biophysical Research Communications 235, n.º 3 (junio de 1997): 713–16. http://dx.doi.org/10.1006/bbrc.1997.6885.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
24

Burke, P. A., K. Lehmannbruinsma y J. S. Powell. "Vascular Endothelial Growth Factor Causes Endothelial Proliferation After Vascular Injury". Biochemical and Biophysical Research Communications 207, n.º 1 (febrero de 1995): 348–54. http://dx.doi.org/10.1006/bbrc.1995.1194.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
25

Enholm, B. "Vascular Endothelial Growth Factor-C A Growth Factor for Lymphatic and Blood Vascular Endothelial Cells". Trends in Cardiovascular Medicine 8, n.º 7 (octubre de 1998): 292–97. http://dx.doi.org/10.1016/s1050-1738(98)00026-7.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
26

Yeh, John, Beom Su Kim y Jennifer Peresie. "Ovarian vascular endothelial growth factor and vascular endothelial growth factor receptor patterns in reproductive aging". Fertility and Sterility 89, n.º 5 (mayo de 2008): 1546–56. http://dx.doi.org/10.1016/j.fertnstert.2007.06.032.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
27

Ishida, Haruhiko, Kiyoshi Doi, Keita Katata y Kenichi Nibu. "Expression of Vascular Endothelial Growth Factor (VEGF) in Nasal Polyps". Nihon Bika Gakkai Kaishi (Japanese Journal of Rhinology) 43, n.º 2 (2004): 194–99. http://dx.doi.org/10.7248/jjrhi1982.43.2_194.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
28

Cao, Yihai, Hua Chen, Li Zhou, Ming-Ko Chiang, Bela Anand-Apte, James A. Weatherbee, Yongda Wang, Faye Fang, John G. Flanagan y Monica Lik-Shing Tsang. "Heterodimers of Placenta Growth Factor/Vascular Endothelial Growth Factor". Journal of Biological Chemistry 271, n.º 6 (9 de febrero de 1996): 3154–62. http://dx.doi.org/10.1074/jbc.271.6.3154.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
29

Olofsson, B., K. Pajusola, A. Kaipainen, G. von Euler, V. Joukov, O. Saksela, A. Orpana, R. F. Pettersson, K. Alitalo y U. Eriksson. "Vascular endothelial growth factor B, a novel growth factor for endothelial cells." Proceedings of the National Academy of Sciences 93, n.º 6 (19 de marzo de 1996): 2576–81. http://dx.doi.org/10.1073/pnas.93.6.2576.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
30

Elkar, Buğra, Mustafa Barış, Meryem Çalışır, Yasemin Çakır, Safiye Aktaş, Merve Tütüncü, M. Kürşat Şimşek, Mustafa Seçil, Osman Yılmaz y Zekiye Altun. "Endothelial Dysfunction in Breast Cancer In-Vivo Model". Proceedings 2, n.º 25 (6 de diciembre de 2018): 1536. http://dx.doi.org/10.3390/proceedings2251536.

Texto completo
Resumen
Although the endothelial dysfunction is related with tumor development, there is no consensus on the suppressive or supportive effect on tumor growth. The goal of the present study was to evaluate endothelial dysfunction related factors in animal breast cancer model that was developed by administrating endothelial nitric oxide synthase blocking agent, Nitro-L-arginine methyl ester hydrochloride (L-NAME). Endothelial dysfunction related main factors such as nitric oxide synthase, interleukin-6, vascular endothelial growth factor receptor-2 and vascular endothelial cadherin were investigated by immunohistochemically in tumor and carotid artery tissues. In tumor tissues apoptosis was determined by TUNEL assay. The level of endothelin-1 in blood was measured by ELISA. İntima-media thickness of carotid artery was evaluated with Doppler-USG measurements. As a result, in this study it was shown that vascular endothelial growth factor receptor-2, endothelin-1, endothelial nitric oxide synthase, interleukin-6, vascular endothelial cadherin and E-selectin molecules play a role in reducing breast tumor growth based on endothelial dysfunction.
Los estilos APA, Harvard, Vancouver, ISO, etc.
31

Jabbour, Mark N., James B. Elder, Christian G. Samuelson, Shabnam Khashabi, Florence M. Hofman, Steven L. Giannotta y Charles Y. Liu. "ABERRANT ANGIOGENIC CHARACTERISTICS OF HUMAN BRAIN ARTERIOVENOUS MALFORMATION ENDOTHELIAL CELLS". Neurosurgery 64, n.º 1 (1 de enero de 2009): 139–48. http://dx.doi.org/10.1227/01.neu.0000334417.56742.24.

Texto completo
Resumen
Abstract OBJECTIVE To identify and characterize the phenotypic and functional differences of endothelial cells derived from cerebral arteriovenous malformations (AVM), as compared with endothelial cells derived from a normal brain. METHODS Isolated AVM brain endothelial cells and control brain endothelial cells were evaluated immunohistochemically for expression of the endothelial cell markers von Willebrand factor and CD31, as well as angiogenic factors including vascular endothelial growth factor A, interleukin-8, and endothelin-1. Vascular endothelial growth factor receptors 1 and 2 were also evaluated using immunohistochemistry techniques. Functional assays evaluated cell proliferation, cytokine production, tubule formation, and cell migration using the modified Boyden chamber technique. RESULTS Endothelial cells derived from AVMs expressed high levels of vascular endothelial growth factor A and significantly overexpressed the vascular endothelial growth factor receptors 1 and 2 (P < 0.05), as compared with control endothelial cells. In addition, comparison to control brain endothelial cells demonstrated that AVM brain endothelial cells proliferated faster, migrated more quickly, and produced aberrant tubule-like structures. CONCLUSION Endothelial cells derived from cerebral AVMs are highly activated cells overexpressing proangiogenic growth factors and exhibiting abnormal functions consistent with highly activated endothelial cells.
Los estilos APA, Harvard, Vancouver, ISO, etc.
32

Masood, Rizwan, Ethel Cesarman, D. Lynne Smith, Parkash S. Gill y Ornella Flore. "Human Herpesvirus-8-Transformed Endothelial Cells Have Functionally Activated Vascular Endothelial Growth Factor/Vascular Endothelial Growth Factor Receptor". American Journal of Pathology 160, n.º 1 (enero de 2002): 23–29. http://dx.doi.org/10.1016/s0002-9440(10)64344-1.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
33

Benzaquen, L. R., A. Nicholson-Weller y J. A. Halperin. "Terminal complement proteins C5b-9 release basic fibroblast growth factor and platelet-derived growth factor from endothelial cells." Journal of Experimental Medicine 179, n.º 3 (1 de marzo de 1994): 985–92. http://dx.doi.org/10.1084/jem.179.3.985.

Texto completo
Resumen
Interactions between endothelium and vascular smooth muscle cells play a major role in the biology of the blood vessel wall. Growth factors released from endothelial cells control in part the normal and pathological proliferation of vascular smooth muscle cells. Endothelial deposits of C5b-9 proteins, the membrane attack complex of complement (MAC), have been found in a variety of pathological tissues in which cell proliferation is an early characteristic abnormality, including atherosclerosis. We have explored a possible bridging role for terminal complement C5b-9 proteins in eliciting focal signals for cell proliferation by releasing growth factors from endothelial cells. We found that both bovine aortic and human umbilical vein cells respond to the MAC by releasing basic fibroblast growth factor and platelet-derived growth factor. These mitogens stimulate DNA synthesis in Swiss 3T3, vascular smooth muscle, and glomerular mesangial cells. Based on these findings, we propose that complement-induced release of mitogens from endothelial cells is a novel pathogenic mechanism for proliferative disorders.
Los estilos APA, Harvard, Vancouver, ISO, etc.
34

Roberts, W. G. y G. E. Palade. "Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor". Journal of Cell Science 108, n.º 6 (1 de junio de 1995): 2369–79. http://dx.doi.org/10.1242/jcs.108.6.2369.

Texto completo
Resumen
The vascular endothelial growth factor (VEGF) was originally described as vascular permeability factor due to its ability to increase microvascular permeability to plasma proteins. However, the vessel types (arteriolar, venular, and capillary) affected by VEGF and the modification of endothelial morphology in response to increased permeability induced by VEGF in vivo have not been precisely documented. By topical application or intradermal injection of recombinant human VEGF-165 we find that VEGF increases the permeability of postcapillary venules as well as muscular venules and capillaries. Surprisingly, we also find that endothelia of small venules and capillaries become fenestrated within 10 minutes of VEGF application. Fenestrations appeared in vascular beds which do not normally have fenestrated endothelium, namely the cremaster muscle and skin. Histamine, saline, and heat-inactivated VEGF do not cause fenestrations. Increased permeability is completely inhibited when VEGF is cleared by immunoprecipitation with anti-VEGF monoclonal antibodies. The VEGF effect on permeability is unlike that of any other mediator described to date since both muscular venules and capillaries are affected.
Los estilos APA, Harvard, Vancouver, ISO, etc.
35

MASUDA, Haruchika. "Vascular Endothelial Growth Factor and Platelets". Internal Medicine 39, n.º 7 (2000): 527–28. http://dx.doi.org/10.2169/internalmedicine.39.527.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
36

Zouggari, Yasmine. "Le VEGF (vascular endothelial growth factor)". Sang thrombose vaisseaux 21, n.º 9 (noviembre de 2009): 494–96. http://dx.doi.org/10.1684/stv.2009.0434.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
37

D'Amore, Patricia A. "Vascular Endothelial Cell Growth Factor-A". American Journal of Pathology 171, n.º 1 (julio de 2007): 14–18. http://dx.doi.org/10.2353/ajpath.2007.070385.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
38

Jackson, Tanisha A., Harry E. Taylor, Deva Sharma, Stephen Desiderio y Sonye K. Danoff. "Vascular Endothelial Growth Factor Receptor-2". Journal of Biological Chemistry 280, n.º 33 (7 de junio de 2005): 29856–63. http://dx.doi.org/10.1074/jbc.m500335200.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
39

Nilsson, Monique y John V. Heymach. "Vascular Endothelial Growth Factor (VEGF) Pathway". Journal of Thoracic Oncology 1, n.º 8 (octubre de 2006): 768–70. http://dx.doi.org/10.1097/01243894-200610000-00003.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
40

Tateishi, Ukihide. "Vascular Endothelial Growth Factor–related Angiogenesis". Radiology 235, n.º 3 (junio de 2005): 1084–85. http://dx.doi.org/10.1148/radiol.2353042072.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
41

Rosengart, Todd K., Edgar G. Chedrawy, Gerald Patejunas y Mauricio Retuarto. "Vascular endothelial growth factor before cells". Journal of Thoracic and Cardiovascular Surgery 129, n.º 3 (marzo de 2005): 696. http://dx.doi.org/10.1016/j.jtcvs.2004.11.018.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
42

Hoeben, Ann, Bart Landuyt, Martin S. Highley, Hans Wildiers, Allan T. Van Oosterom y Ernst A. De Bruijn. "Vascular Endothelial Growth Factor and Angiogenesis". Pharmacological Reviews 56, n.º 4 (diciembre de 2004): 549–80. http://dx.doi.org/10.1124/pr.56.4.3.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
43

Silvestre, Jean-Sébastien. "Vascular Endothelial Growth Factor and Angiogenesis". Circulation 127, n.º 16 (23 de abril de 2013): 1644–46. http://dx.doi.org/10.1161/circulationaha.113.002336.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
44

Nilsson, Monique y John V. Heymach. "Vascular Endothelial Growth Factor (VEGF) Pathway". Journal of Thoracic Oncology 1, n.º 8 (octubre de 2006): 768–70. http://dx.doi.org/10.1016/s1556-0864(15)30404-4.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
45

Dyck, P. J., J. Engelstad y A. Dispenzieri. "Vascular endothelial growth factor and POEMS". Neurology 66, n.º 1 (9 de enero de 2006): 10–12. http://dx.doi.org/10.1212/01.wnl.0000194614.56025.ec.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
46

Isner, Jeffrey M. "Vascular Endothelial Growth Factor in Angiogenesis". Vascular Medicine Review vmr-6, n.º 4 (noviembre de 1995): 311–22. http://dx.doi.org/10.1177/1358863x9500600407.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
47

Nelson, Peter T. y Gregory A. Jicha. "Cerebrospinal Fluid Vascular Endothelial Growth Factor". JAMA Neurology 72, n.º 5 (1 de mayo de 2015): 502. http://dx.doi.org/10.1001/jamaneurol.2015.34.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
48

I. Vento, C. H. J. Wolff, P. J. Sal, S. "Vascular Permeability Factor/Vascular Endothelial Growth Factor in Nasal Polyps". Acta Oto-Laryngologica 120, n.º 543 (enero de 2000): 170–74. http://dx.doi.org/10.1080/000164800454314.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
49

Creamer, D., MH Allen, RW Groves y JNWN Barker. "Circulating vascular permeability factor/vascular endothelial growth factor in erythroderma". Lancet 348, n.º 9034 (octubre de 1996): 1101. http://dx.doi.org/10.1016/s0140-6736(05)64447-9.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
50

Stepanova, T. V., A. N. Ivanov, N. E. Tereshkina, E. B. Popyhova y D. D. Lagutina. "MARKERS OF ENDOTHELIAL DYSFUNCTION: PATHOGENETIC ROLE AND DIAGNOSTIC SIGNIFICANCE". Russian Clinical Laboratory Diagnostics 64, n.º 1 (29 de abril de 2019): 34–41. http://dx.doi.org/10.18821/0869-2084-2019-64-1-34-41.

Texto completo
Resumen
Endothelial dysfunction (ED) is considered one of the pathogenetic mechanisms of a whole range of diseases. Detection of specific biochemical markers in the blood is an effective way to ED diagnostics that characterize the vascular endothelium state. This review highlights the pathogenetic role of the factors synthesized by endotheliocytes whose level changes in biological fluids reflect violations of the endothelium basic physiological properties: vasomotor function, thromboresistance, angiogenesis regulation, barrier and adhesion functions. In particular, the participation of nitric oxide metabolites, asymmetric dimethylarginine, endothelin-1, metabolic products of arachidonic acid, von Willebrand factor, thrombomodulin, vascular endothelial growth factor, vasohibine-1 and adhesion molecules in the onset and development of ED are reviewed. The diagnostic significances of factors damaging endothelium, such as C-reactive protein, homocysteine and 8-hydroxy-2’-deoxyguanosine, are discussed. In addition, the literature data of recent years about the prospects of clinical implication the detection of the above-mentioned factors which indicates structural and functional endothelial cells damage are given. Particular attention is paid to the ED markers detection prognostic significance and the possibility of their practical use for the ED diagnosis. The search of literature for the current review was conducted in RSIC, CyberLeninka, Scopus, Web of Science, MedLine and PubMed databases from 2012 to 2018 using the following keywords: endothelial dysfunction, nitric oxide, asymmetric dimethylarginine, endothelin-1, prostacyclin, thromboxane A2, epoxyeicosatrienoic acids, von Willebrand factor, thrombomodulin, vascular endothelial growth factor, vasohibin-1, adhesive molecules, C-reactive protein, homocysteine, and 8-hydroxy-2-deoxyguanosine.
Los estilos APA, Harvard, Vancouver, ISO, etc.
También puede estar interesado en las bibliografías sobre el tema "Vascular endothelial growth factor" para otros tipos de fuentes:
Tesis Libros
Ofrecemos descuentos en todos los planes premium para autores cuyas obras están incluidas en selecciones literarias temáticas. ¡Contáctenos para obtener un código promocional único!

Pasar a la bibliografía